These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19714263)

  • 1. Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin) for AMD followed by controlateral sympathetic ophthalmia.
    Brouzas D; Koutsandrea C; Moschos M; Papadimitriou S; Ladas I; Apostolopoulos M
    Clin Ophthalmol; 2009; 3():457-9. PubMed ID: 19714263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic ophthalmia in fellow eye after vitrectomy for massive subretinal hemorrhage secondary to polypoidal choroidal vasculopathy.
    Suetsugu T; Yasukawa T; Uemura A; Higaki M; Ogura Y
    Int Med Case Rep J; 2018; 11():293-296. PubMed ID: 30464649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
    Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A one-year follow-up study of ocular and systemic complications of intravitreal injection of bevacizumab (Avastin).
    Fasih U; Shaikh N; Rahman A; Sultan S; Fehmi MS; Shaikh A
    J Pak Med Assoc; 2013 Jun; 63(6):707-10. PubMed ID: 23901669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone acetonide: a change in a paradigm.
    Jonas JB
    Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia.
    Jonas JB
    Am J Ophthalmol; 2004 Feb; 137(2):367-8. PubMed ID: 14962439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.
    Garg S; Brod R; Kim D; Lane RG; Maguire J; Fischer D
    Clin Exp Ophthalmol; 2008 Apr; 36(3):252-6. PubMed ID: 18412594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone acetonide in sympathetic ophthalmia.
    Ozdemir H; Karacorlu M; Karacorlu S
    Graefes Arch Clin Exp Ophthalmol; 2005 Jul; 243(7):734-6. PubMed ID: 15756580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
    J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A; Stinnett S; Fekrat S
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
    Jonas JB; Kreissig I; Degenring R
    Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.
    el Matri L; Chebil A; Kort F; Bouraoui R; Baklouti K; Mghaieth F
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):779-84. PubMed ID: 20169357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degeneration.
    Jonas JB; Ihloff AK; Harder B; Kreissig I; Schlichtenbrede F; Libondi T; Spandau UH; Vossmerbaeumer U
    Ophthalmic Res; 2009; 41(1):21-7. PubMed ID: 18849638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectivity and safety of bevacizumab intravitreal injections for exudative age-related macular degeneration treatment--6 months observations].
    Małgorzata F
    Klin Oczna; 2010; 112(7-9):213-6. PubMed ID: 21121123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
    Jonas JB; Akkoyun I; Budde WM; Kreissig I; Degenring RF
    Arch Ophthalmol; 2004 Feb; 122(2):218-22. PubMed ID: 14769599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab for macular edema due to proton beam radiotherapy: Favorable results shown after eighteen months follow-up.
    Loukianou E; Brouzas D; Georgopoulou E; Koutsandrea C; Apostolopoulos M
    Ther Clin Risk Manag; 2010 May; 6():249-52. PubMed ID: 20526443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal steroid slow-release device replacing repeated intravitreal triamcinolone injections for sympathetic ophthalmia.
    Jonas JB; Rensch F
    Eur J Ophthalmol; 2008; 18(5):834-6. PubMed ID: 18850570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.